# A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI

> **NCT03526367** · PHASE4 · WITHDRAWN · sponsor: **Shenyang Northern Hospital**

## Conditions studied

- Contrast-induced Acute Kidney Injury
- ST Elevation Myocardial Infarction
- Primary PCI
- Rosuvastatin
- Hydration

## Interventions

- **DRUG:** hydration plus rosuvastatin therapy
- **DRUG:** Standard therapy

## Key facts

- **NCT ID:** NCT03526367
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-02-20
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study withdrawn for no sufficient fund support.
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526367, "A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03526367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*